格隆汇2月20日丨复星医药(600196.SH)公布,控股子公司复星健康拟出资人民币3,000万元认缴其控股子公司上海卓尔荟等值新增注册资本,上海卓尔荟的其他三方股东均放弃优先认购权。本次增资完成后,上海卓尔荟的注册资本将由人民币10,200万元增至13,200万元,其中:复星健康持有上海卓尔荟的股权比例将由57.5363%增至67.1872%。本次增资前后,上海卓尔荟均为本集团合并报表子公司。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.